Published trials showed that the treatment with GLP1-RA reduced the risk of MACE and slowed the development of albuminuria in diabetic patients, demonstrating a direct cardio and reno-protective action of GLP1-RA, regardless the effect on glycemic control (60, 61)
Abbasinejad, MD, and the team explain that Wegovy starts working gradually rather than immediately, with most patients noticing early appetite changes within 12 weeks of treatment
Direct oral anticoagulants (DOACs): From the laboratory point of view
Lcell saturation assay: How exactly does allulose exert its effects
From a pharmaceutical perspective, our approved dosing regimens exist for a reason
A refrigerator is not necessary, but a cool cabinet is preferable to a humid, warm bathroom